COVID-19 and liver dysfunction: A systematic review and meta-analysis of retrospective studies
- PMID: 32445489
- PMCID: PMC7283797
- DOI: 10.1002/jmv.26055
COVID-19 and liver dysfunction: A systematic review and meta-analysis of retrospective studies
Abstract
Recently, Coronavirus Disease 2019 (COVID-19) pandemic is the most significant global health crisis. In this study, we conducted a meta-analysis to find the association between liver injuries and the severity of COVID-19 disease. Online databases, including PubMed, Web of Science, Scopus, and Science direct, were searched to detect relevant publications up to 16 April 2020. Depending on the heterogeneity between studies, a fixed- or random-effects model was applied to pool data. Publication bias Egger's test was also performed. Meta-analysis of 20 retrospective studies (3428 patients), identified that patients with a severe manifestation of COVID-19 exhibited significantly higher levels of alanine aminotransferase, aspartate aminotransferase, and bilirubin values with prolonged prothrombin time. Furthermore, lower albumin level was associated with a severe presentation of COVID-19. Liver dysfunction was associated with a severe outcome of COVID-19 disease. Close monitoring of the occurrence of liver dysfunction is beneficial in early warning of unfavorable outcomes.
Keywords: COVID-19; SARS-CoV-2; liver function; meta-analysis; outcome.
© 2020 Wiley Periodicals LLC.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Figures
References
-
- World Health Organization (WHO) . Coronavirus disease 2019 (COVID‐19) Situation Report—84. World Heal Organ. 2020;323:1122. 10.1001/jama.2020.2633 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
